Cargando…
Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study
BACKGROUND: Immunotherapy is currently applied in the first-line treatment regimens for numerous advanced cancers, especially advanced lung cancer. Immune-related adverse events (irAEs) resulting from immunotherapy can vary in severity and cause a substantial symptom burden to patients. However, the...
Autores principales: | Deng, Yuanle, Hu, Han, Jia, Rong, Dai, Wei, Wang, Dengfeng, Zhang, Purong, Zhang, Peng, Cheng, Kai, Tang, Jianning, Wen, Yan, Zhou, Xiang, Shi, Qiuling, Xiong, Zhujuan, Zhou, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199466/ https://www.ncbi.nlm.nih.gov/pubmed/37208661 http://dx.doi.org/10.1186/s12890-023-02432-5 |
Ejemplares similares
-
ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis
por: Lingner, Heidrun, et al.
Publicado: (2015) -
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study
por: Delombaerde, Danielle, et al.
Publicado: (2023) -
Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first‐line chemotherapy: A multicenter prospective cohort study
por: Ai, Bin, et al.
Publicado: (2020) -
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023) -
Practice of adjunctive treatments in critically ill COVID–19 patients—rational for the multicenter observational PRoAcT-COVID study in The Netherlands
por: Valk, Christel M. A., et al.
Publicado: (2021)